Boyce John M, Ligi Cathy, Kohan Cindy, Dumigan Diane, Havill Nancy L
Infectious Diseases Section, Hospital of Saint Raphael, Yale University School of Medicine, 1450 Chapel Street, New Haven, CT 06511, USA.
Infect Control Hosp Epidemiol. 2006 May;27(5):479-83. doi: 10.1086/504362. Epub 2006 Apr 26.
To determine whether there is an association between the increasing use of alcohol-based hand rubs (ABHRs) and the increased incidence of Clostridium difficile-associated disease (CDAD).
A 500-bed university-affiliated community teaching hospital.
Use of ABHRs during the period 2000-2003 was expressed as the number of liters of ABHR used per 1000 patient-days. The proportion of hand hygiene episodes performed by using an ABHR was determined by periodic observational surveys. CDAD was defined as a physician-ordered stool assay positive for C. difficile toxin A or A/B. The incidence of CDAD was expressed as the number of unique patients who had 1 or more positive CDAD test results per 1,000 patient-days.
During 2000-2003, the use of ABHR increased 10-fold, from 3 to greater than 30 L/1,000 patient-days (P<.001). The proportion of hand hygiene episodes performed using an ABHR increased from 10% to 85% (P<.001). The incidence of CDAD in 2000, 2001, 2002, and 2003 was 1.74, 2.33, 1.14, and 1.18 cases/1,000 patient-days, respectively.
Despite a significant and progressive increase in the use of ABHRs in our facility during a 3-year period, there was no evidence that the incidence of CDAD increased. These findings suggest that factors other than the increased use of ABHRs are responsible for the increasing incidence of CDAD noted since 2000 in other facilities.
确定酒精基手部消毒剂(ABHRs)使用量的增加与艰难梭菌相关疾病(CDAD)发病率的上升之间是否存在关联。
一家拥有500张床位的大学附属社区教学医院。
2000 - 2003年期间ABHRs的使用量以每1000个患者日使用的ABHR升数表示。通过定期观察性调查确定使用ABHR进行手卫生的比例。CDAD定义为医生开具的粪便检测艰难梭菌毒素A或A/B呈阳性。CDAD的发病率以每1000个患者日有1次或更多次CDAD检测结果呈阳性的独特患者数量表示。
在2000 - 2003年期间,ABHRs的使用量增加了10倍,从3升/1000个患者日增加到超过30升/1000个患者日(P <.001)。使用ABHR进行手卫生的比例从10%增加到85%(P <.001)。2000年、2001年、2002年和2003年CDAD的发病率分别为1.74、2.33、1.14和1.18例/1000个患者日。
尽管在3年期间我们机构中ABHRs的使用量显著且逐步增加,但没有证据表明CDAD的发病率增加。这些发现表明,自2000年以来其他机构中CDAD发病率上升的原因是ABHRs使用量增加以外的因素。